ARIAD Pharma (ARIA) Tops Q3 EPS by 7c

November 7, 2016 7:36 AM EST

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

ARIAD Pharma (NASDAQ: ARIA) reported Q3 EPS of ($0.12), $0.07 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $34.3 million versus the consensus estimate of $42.93 million.

ARIAD Pharma reaffirmed FY2016 guidance.

For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment